SCHEMBL20333327

SCHEMBL20333327

CCC(C)c1cn(I)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20341020 0.79 — —
SCHEMBL12854187 0.78 PGR (0.32) —
SCHEMBL25141974 0.76 IDO1 (0.36) —
SCHEMBL18790863 0.76 IDO1 (0.34) —
SCHEMBL21419563 0.74 ACHE (0.35) —
SCHEMBL22280519 0.74 ACHE (0.35) —
SCHEMBL22567310 0.70 — —
SCHEMBL26764676 0.69 — —
SCHEMBL19732444 0.69 IRAK4 (0.34) —
SCHEMBL25905319 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018116178-A1 ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS NOVARTIS AG (CH) 2018-06-28 — — WO disclosed
Send feedback